The Clinical Side of Bipolar Disorders

Abstract

This article summarizes key facts on the epidemiology, diagnosis and clinical treatment of bipolar disorder. Bipolar disorder is a common mental disorder with a high disease burden, but still does not get the attention it deserves in research and clinical training. The nature of the disorder is complex, but it is apparent that biological factors are decisive. Thus, understanding the biological systems and cycles affected will become crucial for developing more targeted interventions. Currently, standard treatments seem to have a low specificity for Bipolar Disorder, and only few experimental interventions target directly potential underlying disturbances as HPA axis or circadian clock dysregulation. Systemic analysing and modelling of bipolar disorder is a novel approach which might open up new ways in developing more selective therapies.

References

• 1 Angst J. Do many patients with depression suffer from bipolar disorder?.  Can J Psychiatry. 2006;  51 3-5
• 2 American Psychiatric Association .Diagnostic and statistical manual of mental disorders.. 4th revised ed. Washington DC: American Psychiatric Press; 1994
• 3 Merikangas KR, Akiskal HS, Angst J. et al . Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.  Arch Gen Psychiatry. 2007;  64 543-552
• 4 Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases.  J Affect Disord. 2003;  73 123-131
• 5 Phelps J, Angst J, Katzow J. et al . Validity and utility of bipolar spectrum models.  Bipolar Disord. 2008;  10 179-193
• 6 Regeer EJ, ten HM, Rosso ML. et al . Prevalence of bipolar disorder in the general population: a Reappraisal Study of the Netherlands Mental Health Survey and Incidence Study.  Acta Psychiatr Scand. 2004;  110 374-382
• 7 Angst J. The epidemiology of depressive disorders.  Eur Neuropsychopharmacol. 1995;  5 (Suppl) 95-98
• 8 Ghaemi SN, Sachs GS, Chiou AM. et al . Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?.  J Affect Disord. 1999;  52 135-144
• 9 Suppes T, Leverich GS, Keck PE. et al . The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients.  J Affect Disord. 2001;  67 45-59
• 10 Gonzalez-Pinto A, Aldama A, Mosquera F. et al . Epidemiology, diagnosis and management of mixed mania.  CNS Drugs. 2007;  21 611-626
• 11 Kilzieh N, Akiskal HS. Rapid-cycling bipolar disorder. An overview of research and clinical experience.  Psychiatr Clin North Am. 1999;  22 585-607
• 12 Kraepelin E. Psychiatrie. Ein Lehrbuch für Studierende und Ärzte.. 6 ed. Leipzig: Barth; 1899
• 13 Swann AC, Bowden CL, Morris D. et al . Depression during mania. Treatment response to lithium or divalproex.  Arch Gen Psychiatry. 1997;  54 37-42
• 14 McElroy SL, Keck PE, Pope HG. et al . Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania.  Am J Psychiatry. 1992;  149 1633-1644
• 15 Perugi G, Akiskal HS, Micheli C. et al . Clinical subtypes of bipolar mixed states: validating a broader European definition in 143 cases.  J Affect Disord. 1997;  43 169-180
• 16 Suppes T, Mintz J, McElroy SL. et al . Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon.  Arch Gen Psychiatry. 2005;  62 1089-1096
• 17 Dunner DL, Fieve RR. Clinical factors in lithium carbonate prophylaxis failure.  Arch Gen Psychiatry. 1974;  30 229-233
• 18 Kupka RW, Luckenbaugh DA, Post RM. et al . Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients.  Am J Psychiatry. 2005;  162 1273-1280
• 19 Sjoholm LK, Backlund L, Cheteh EH. et al . CRY2 is associated with rapid cycling in bipolar disorder patients.  PLoS One. 2010;  5 e12632
• 20 Daban C, Colom F, Sanchez-Moreno J. et al . Clinical correlates of first-episode polarity in bipolar disorder.  Compr Psychiatry. 2006;  47 433-437
• 21 Angst J. Do many patients with depression suffer from bipolar disorder?.  Canadian journal of psychiatry. 2006;  51 3-5
• 22 World Health Organization .The ICD-10 Classification of Mental and behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines.. Geneva: WHO; 1992
• 23 Goldberg JF, Perlis RH, Bowden CL. et al . Manic symptoms during depressive episodes in 1 380 patients with bipolar disorder: findings from the STEP-BD.  Am J Psychiatry. 2009;  166 173-181
• 24 Goodwin FK, Jamison KR. Manic -depressive illness.. 2 ed. New York: Oxford University Press; 2007
• 25 Akiskal HS, Walker P, Puzantian VR. et al . Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors.  J Affect Disord. 1983;  5 115-128
• 26 Perlis RH, Brown E, Baker RW. et al . Clinical features of bipolar depression versus major depressive disorder in large multicenter trials.  Am J Psychiatry. 2006;  163 225-231
• 27 Mitchell PB, Malhi GS. Bipolar depression: phenomenological overview and clinical characteristics.  Bipolar Disord. 2004;  6 530-539
• 28 Winokur G, Coryell W, Endicott J. et al . Further distinctions between manic-depressive illness (bipolar disorder) and primary depressive disorder (unipolar depression).  Am J Psychiatry. 1993;  150 1176-1181
• 29 Hegerl U, Bottner AC, Holtschmidt-Taschner B. et al . Onset of depressive episodes is faster in patients with bipolar versus unipolar depressive disorder: evidence from a retrospective comparative study.  J Clin Psychiatry. 2008;  69 1075-1080
• 30 Mitchell PB, Goodwin GM, Johnson GF. et al . Diagnostic guidelines for bipolar depression: a probabilistic approach.  Bipolar Disord. 2008;  10 144-152
• 31 Simpson SG, Jamison KR. The risk of suicide in patients with bipolar disorders.  J Clin Psychiatry. 1999;  60 (S 02) 53-56
• 32 Morselli P, Elgie R, Cesana B. GAMIAN-Europe/BEAM survey II: cross-national analysis of unemployment, family history, treatment satisfaction and impact of the bipolar disorder on life style.  Bipolar Disord. 2004;  6 487-497
• 33 Maina G, Albert U, Bellodi L. et al . Health-related quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes.  J Clin Psychiatry. 2007;  68 207-212
• 34 Shi L, Thiebaud P, McCombs JS. The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program.  J Affect Disord. 2004;  82 373-383
• 35 Woods SW. The economic burden of bipolar disease.  J Clin Psychiatry. 2000;  61 (Supp 13) 38-41
• 36 Angst J. Bipolar disorder – a seriously underestimated health burden.  Eur Arch Psychiatry Clin Neurosci. 2004;  254 59-60
• 37 Hakkaart-van RL, Hoeijenbos MB, Regeer EJ. et al . The societal costs and quality of life of patients suffering from bipolar disorder in the Netherlands.  Acta Psychiatr Scand. 2004;  110 383-392
• 38 Runge C, Grunze H. Jährliche Krankheitskosten bipolarer Störungen in Deutschland.  Nervenarzt. 2004;  75 896-903
• 39 The World Health Organisation . The World Health Report 2001, Mental Health: New understanding, new hope.  Chapter 2: Burden of mental and behavioural disorder. http://www.who.int/whr/2001/main/en/pdf/GGTSPU-1368-326547-DAT/chapter2.en.pdf 2002
• 40 Henry C, Sorbara F, Lacoste J. et al . Antidepressant-induced mania in bipolar patients: identification of risk factors.  J Clin Psychiatry. 2001;  62 249-255
• 41 Rihmer Z, Szadoczky E, Furedi J. et al . Anxiety disorders comorbidity in bipolar I, bipolar II and unipolar major depression: results from a population-based study in Hungary.  J Affect Disord. 2001;  67 175-179
• 42 Sherwood BE, Suppes T, Adinoff B. et al . Drug abuse and bipolar disorder: comorbidity or misdiagnosis?.  J Affect Disord. 2001;  65 105-115
• 43 Rihmer Z, Kiss K. Bipolar disorders and suicide risk.  Clinical Approaches in Bipolar Disorders. 2002;  1 15-21
• 44 Oedegaard KJ, Fasmer OB. Is migraine in unipolar depressed patients a bipolar spectrum trait?.  J Affect Disord. 2005;  84 233-242
• 45 Regenold WT, Thapar RK, Marano C. et al . Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use.  J Affect Disord. 2002;  70 19-26
• 46 Kupka RW, Altshuler LL, Nolen WA. et al . Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder.  Bipolar Disord. 2007;  9 531-535
• 47 Berk M, Dodd S. Bipolar II disorder: a review.  Bipolar Disord. 2005;  7 11-21
• 48 Rihmer Z, Pestality P. Bipolar II disorder and suicidal behavior.  Psychiatr Clin North Am. 1999;  22 667-673
• 49 Dittmann S, Hennig-Fast K, Gerber S. et al . Cognitive functioning in euthymic bipolar I and bipolar II patients.  Bipolar Disord. 2008;  10 877-887
• 50 Dittmann S, Seemuller F, Grunze HC. et al . The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study.  J Clin Psychiatry. 2008;  69 899-906
• 51 Robinson LJ, Thompson JM, Gallagher P. et al . A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder.  J Affect Disord. 2006;  93 105-115
• 52 Berk M, Berk L. Mood stabilizers and treatment adherence in bipolar disorder: addressing adverse events.  Ann Clin Psychiatry. 2003;  15 217-224
• 53 Angst F, Stassen HH, Clayton PJ. et al . Mortality of patients with mood disorders: follow-up over 34–38 years.  J Affect Disord. 2002;  68 167-181
• 54 Sowden GL, Huffman JC. The impact of mental illness on cardiac outcomes: A review for the cardiologist.  Int J Cardiol. 2008; 
• 55 Grunze H, Vieta E, Goodwin GM. et al . The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania.  World J Biol Psychiatry. 2009;  10 85-116
• 56 Grunze H, Vieta E, Goodwin GM. et al . The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.  World J Biol Psychiatry. 2010;  11 81-109
• 57 Grunze H, Vieta E, Goodwin GM. et al . WFSBP Task Force on Treatment Guidelines for Bipolar Disorders The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2011 on the Maintenance treatment of Bipolar Disorder.  World J Biol Psychiatry. 2011;  In Press
• 58 Tohen M, Zarate CA, Hennen J. et al . The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence.  Am J Psychiatry. 2003;  160 2099-2107
• 59 Solomon DA, Leon AC, Coryell WH. et al . Longitudinal course of bipolar I disorder: duration of mood episodes.  Arch Gen Psychiatry. 2010;  67 339-347
• 60 Newberg AR, Catapano LA, Zarate CA. et al . Neurobiology of bipolar disorder.  Expert Rev Neurother. 2008;  8 93-110
• 61 Heuser I, Yassouridis A, Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.  J Psychiatr Res. 1994;  28 341-356
• 62 Rybakowski JK, Twardowska K. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness.  J Psychiatr Res. 1999;  33 363-370
• 63 Schmider J, Lammers CH, Gotthardt U. et al . Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.  Biol Psychiatry. 1995;  38 797-802
• 64 Watson S, Del Estal D, Smith M. et al . The hypothalamic-pituitary-adrenal axis in euthymic bipolar patients.  J Psychopharmacol. 2001;  15 (suppl) B7
• 65 Lauer CJ, Schreiber W, Modell S. et al . The Munich vulnerability study on affective disorders: overview of the cross-sectional observations at index investigation.  J Psychiatr Res. 1998;  32 393-401
• 66 Modell S, Lauer CJ, Schreiber W. et al . Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders.  Neuropsychopharmacology. 1998;  18 253-262
• 67 Harris TO, Borsanyi S, Messari S. et al . Morning cortisol as a risk factor for subsequent major depressive disorder in adult women.  Br J Psychiatry. 2000;  177 505-510
• 68 Gallagher P, Malik N, Newham J. et al . Antiglucocorticoid treatments for mood disorders.  Cochrane Database Syst Rev. 2008;  CD005168
• 69 Young AH, Gallagher P, Watson S. et al . Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder.  Neuropsychopharmacology. 2004;  29 1538-1545
• 70 Sack DA, James SP, Rosenthal NE. et al . Deficient nocturnal surge of TSH secretion during sleep and sleep deprivation in rapid-cycling bipolar illness.  Psychiatry Res. 1988;  23 179-191
• 71 Joffe RT, Sokolov STH. Hormones and Bipolar Affective Disorder.. In:, Young LT,, Joffe RT,, eds. Bipolar disorder – Biological models and their clinical application. New York: Marcel Dekker; 1997: 81-92
• 72 Bauer MS, Whybrow PC. Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study.  Arch Gen Psychiatry. 1990;  47 435-440
• 73 Bauer M, London ED, Rasgon N. et al . Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression.  Mol Psychiatry. 2005;  10 456-469
• 74 Bauer M, Hellweg R, Graf KJ. et al . Treatment of refractory depression with high-dose thyroxine.  Neuropsychopharmacology. 1998;  18 444-455
• 75 Kupka RW, Nolen WA, Post RM. et al . High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure.  Biol Psychiatry. 2002;  51 305-311
• 76 Wirz-Justice A, Quinto C, Cajochen C. et al . A rapid-cycling bipolar patient treated with long nights, bedrest, and light.  Biol Psychiatry. 1999;  45 1075-1077
• 77 Wirz-Justice A, Benedetti F, Berger M. et al . Chronotherapeutics (light and wake therapy) in affective disorders.  Psychological medicine. 2005;  35 939-944
• 78 Wu JC, Kelsoe JR, Schachat C. et al . Rapid and Sustained Antidepressant Response with Sleep Deprivation and Chronotherapy in Bipolar Disorder.  Biol Psychiatry. 2009; 
• 79 Riemann D, Voderholzer U, Berger M. Sleep and sleep-wake manipulations in bipolar depression.  Neuropsychobiology. 2002;  45 (Suppl. 1) 13-19
• 80 Colombo C, Benedetti F, Barbini B. et al . Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression.  Psychiatry Res. 1999;  86 267-270
• 81 Dolder CR, Nelson M, Snider M. Agomelatine treatment of major depressive disorder.  Ann Pharmacother. 2008;  42 1822-1831
• 82 Calabrese JR, Guelfi JD, Perdrizet-Chevallier C. Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data.  Bipolar Disord. 2007;  9 628-635
• 83 Macedo-Soares MB, Moreno RA, Rigonatti SP. et al . Efficacy of electroconvulsive therapy in treatment-resistant bipolar disorder: a case series.  J ECT. 2005;  21 31-34
• 84 Silverstone PH, Silverstone T. A review of acute treatments for bipolar depression.  Int Clin Psychopharmacol. 2004;  19 113-124
• 85 Hallam KT, Smith DI, Berk M. Differences between subjective and objective assessments of the utility of Electroconvulsive therapy in patients with bipolar and unipolar depression.  J Affect Disord. 2009;  112 212-218
• 86 Angst J. Switch from depression to mania–a record study over decades between 1920 and 1982.  Psychopathology. 1985;  18 140-154
• 87 Nahas Z, Kozel FA, Li X. et al . Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy.  Bipolar Disord. 2003;  5 40-47
• 88 Xia G, Gajwani P, Muzina DJ. et al . Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation.  Int J Neuropsychopharmacol. 2008;  11 119-130

Correspondence